<DOC>
	<DOCNO>NCT00046137</DOCNO>
	<brief_summary>The purpose study compare treatment teriparatide raloxifene teriparatide alone . The study evaluate side effect may associate two drug may help determine whether teriparatide raloxifene together help patient osteoporosis teriparatide alone .</brief_summary>
	<brief_title>Combined Use Teriparatide Raloxifene Postmenopausal Women With Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<mesh_term>Raloxifene Hydrochloride</mesh_term>
	<criteria>Inclusion Criteria Must diagnose osteoporosis . Must female , age 45 85 . Must least 5 year postmenopausal . Must free severe chronically disable condition . Must able properly use injection device . Exclusion Criteria Must bone diseases osteoporosis . Must history certain cancer . Must certain medical disease ( inflammatory bowel disease , malabsorption syndrome , kidney bladder stone , venous thrombus embolus , recent vaginal bleeding due unknown cause ) . Must take currently take certain type medicine . Must know allergy study agent SERM .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>